Some thoughts before the July 31st.  * Is the #C4CT

New Post Public Reply Private Reply Replies (2) Message Board
Mauibound

Some thoughts before the July 31st. 

* Is the #C4CT website up to date?
* Is Dr. Kirby presenting on behalf of the company, per GC
* if he is, is Dr. Kirby being introduced as a BOA or CMO
I have emailed Aimee with the above questions and will post any updates or responses.

Questions I don't have an answers to:

Can the Gov't give Grants or Contracts to not yet Approved FDA diagnostic tests?

IE - Fed grants or contracts for testing soldiers 

"As we prepare to launch our blood diagnostic LymPro Test ® for Alzheimer's disease in the second half of 2014, we believe it is critical to identify populations who are at the highest risk of developing Alzheimer's disease so that we may conduct clinical research to identify common pathways among those who progress to Alzheimer's disease," said Gerald E. Commissiong, President & CEO of Amarantus. "Traumatic Brain Injury is a clear risk factor that we believe accelerates an already-present predisposition for Alzheimer's disease. Current and former athletes and soldiers who have been exposed to multiple concussions and sub-concussive events should be on high alert for symptomatology of early Alzheimer's disease."

As mentioned in the PR specifically attached w/the #C4CT Summit.
http://www.marketwatch.com/story/amarantus-an..._news_stmp

Without getting into ANY political debates, with having The Honorable Chaka Fattah Member of Congress giving the Opening Keynote Address and his personal mission in wanting to address Alzheimer's, TBI and the correlation to the two, I wonder is there is a connection that we do not know about.

GC has said many times over in essence  -
I don't worry about share price. Let the science speak for itself.

And yet, he is the one when asked 
"@G_Commish Estimate of range of where you'd like see share price before reverse split/up-list? Glad it's in 2015."
GC voluntarily offers up ".@eyedo_2015 We do not know a reverse is needed. #AskAMBS"

https://mobile.twitter.com/G_Commish/status/4...8794665984

The worst thing a small co. can do is call attention to itself on a global scale and produce failing numbers. GC has intimated this, so why on Earth would he 
A) Intro $AMBS at AAIC 
B) let it be known he will be delivering new updated #'s at the #C4CT
C) bring up the idea of possibly NOT needing an R/S
D) bring up the terms like  Financial Engineering 
E) continually speak of taking care of long term investors
F) have an unwavering stance that LymPro Test(R) to market & up listing will both happen 2H14

He would have to be an absolute CLOWN to continually make remarks and statements that are so entirely outlandish and FALSE,  no?

That's crazy talk, though, none are promises, but legitimate goals set forth by him. For whatever reasoning, he sees it as financially plausible.

What news will be coming out soon regarding MANF. Not JV or partnering or even grants, all possible too, but as in research in regards to:

Wolfram's Syndrome and MANF as Dr. Urano aims to cure! As in eradicate a disease. 

Scientists rarely take time to celebrate, Japanese scientists celebrate even less, because the science is not about them, it's about their team, the disease and the common goal to eradicate that disease. 

So, for Dr. Urano to publicly announce he has just submitted a paper and show himself "celebrating", that speaks volumes.

"Just sent out an research article on Wolfram syndrome. Cheers!"  Fumi instagram.com/p/qSvNTztW1N/
6:44pm - 10 Jul 14

And then to follow it up by Stating his intentions of coming up with a cure and the process will be TROUGH MANF, well I don't have a clue what else anyone needs to be reassured in this company, the people who are running it, associated with it  and everyone on the forefront of finding cures...

Oh and last before I get off my soapbox for the day, Any CLOWN who refers to that other test AMYVID other than AMYVID is dismissing and degrading every single person who has worked on it  and every single patient and family member that is dealing or has dealt with that disease.
Refer to it by its proper name you Arrogant CLOWN and pay respects to the community who is working on helping those who are suffering!

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 6

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 6

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading
Microplastics Webinar: Navigating Complex Regulations

Updated Category News Views 7

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

Continue Reading
Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 4

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 5

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
NSF Backs New Space Projects: Cooling & Drug Delivery

Updated Category News Views 7

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 7

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading
NORD Honors Innovators Shaping Rare Disease Treatment

Updated Category News Views 9

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

Continue Reading
illycaffè's B Corp™ Recertification Reflects Bold Commitment

Updated Category News Views 6

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Continue Reading
Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 6

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading

Top 5 Most Recently Viewed Articles

Experience the Flavors of Perú at Mucho Gusto Festival in NYC

Updated Category News Views 286

Perú Mucho Gusto Culinary Festival Launches in New York City Get ready for a spectacular celebration of Peruvian cuisine as the Perú Mucho Gusto Culinary Festival descends upon New York City. This vibrant festival promises to showcase the rich flavors, culinary creativity, and cultural traditions of Perú. Culinary enthusiasts and curious foodies will find themselves...

Continue Reading
Aura Minerals Reports Strong Q3 2024 Financial Results

Updated Category News Views 122

Aura Minerals Reports Strong Q3 2024 Financial Results Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) is excited to share its unaudited consolidated financial statements and management discussion, revealing positive trends for Q3 2024. The reporting period concluded on September 30, 2024. All amounts stated are in thousands of U.S. dollars unless noted...

Continue Reading
Albion Crown VCT PLC: Insights on Voting Rights and Capital

Updated Category News Views 108

Understanding Voting Rights and Share Capital Albion Crown VCT PLC serves as an example of transparency and compliance within the market. This detailed overview provides insights regarding the company's voting rights and capital structure, empowering shareholders and investors alike to understand their stake in the company. Current Issued Share Capital Details In...

Continue Reading
KBRA Releases Initial Ratings for FREMF 2024-K167 Securities

Updated Category News Views 344

KBRA Announces Preliminary Ratings for FREMF 2024-K167 KBRA is excited to share that it has assigned preliminary ratings to various classes of the FREMF Series 2024-K167 mortgage pass-through certificates and Freddie Mac's structured pass-through certificates (SPCs) for the same series. This significant transaction totals approximately $1.2 billion in CMBS multi-borrower...

Continue Reading
Transforming $1000: Liberty Media's Phenomenal Growth Story

Updated Category News Views 201

Transforming $1000: Liberty Media's Phenomenal Growth Story Liberty Media (NASDAQ: FWONK) has consistently delivered exceptional results, outperforming the market over the last decade. With an impressive annualized return of 11.68%, it has attracted the attention of numerous investors looking to grow their wealth. Currently, the company's market capitalization stands at...

Continue Reading